These will
include tricyclic antidepressants (TCAs; amitriptyline, clomipramine, nortriptyline, desipramine, imipramine, etc), selective serotonin reuptake inhibitors (SSRIs; escitalopram, fluoxetine, paroxetine, sertraline, etc) and serotonin - norepinephrine reuptake inhibitors (SNRIs;
venlafaxine, duloxetine), as well as novel agents mirtazapine and nefazodone.